tetano
Editor, Senior Moderator
Open Biol
. 2024 Jun;14(6):230349.
doi: 10.1098/rsob.230349. Epub 2024 Jun 12. Risk factors for severe COVID-19 disease increase SARS-CoV-2 infectivity of endothelial cells and pericytes
Luca Biasetti[SUP] 1 [/SUP], Nikos Zervogiannis[SUP] 1 [/SUP], Kira Shaw[SUP] 1 [/SUP], Harry Trewhitt[SUP] 1 [/SUP], Louise Serpell[SUP] 2 [/SUP], Dalan Bailey[SUP] 3 [/SUP], Edward Wright[SUP] 4 [/SUP], Catherine N Hall[SUP] 1 [/SUP]
Affiliations
Coronavirus disease 2019 (COVID-19) was initially considered a primarily respiratory disease but is now known to affect other organs including the heart and brain. A major route by which COVID-19 impacts different organs is via the vascular system. We studied the impact of apolipoprotein E (APOE) genotype and inflammation on vascular infectivity by pseudo-typed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viruses in mouse and human cultured endothelial cells and pericytes. Possessing the APOE4 allele or having existing systemic inflammation is known to enhance the severity of COVID-19. Using targeted replacement human APOE3 and APOE4 mice and inflammation induced by bacterial lipopolysaccharide (LPS), we investigated infection by SARS-CoV-2. Here, we show that infectivity was higher in murine cerebrovascular pericytes compared to endothelial cells and higher in cultures expressing APOE4. Furthermore, increasing the inflammatory state of the cells by prior incubation with LPS increased infectivity into human and mouse pericytes and human endothelial cells. Our findings provide insights into the mechanisms underlying severe COVID-19 infection, highlighting how risk factors such as APOE4 genotype and prior inflammation may exacerbate disease severity by augmenting the virus's ability to infect vascular cells.
Keywords: APOE; COVID-19; SARS-CoV-2; endothelial cell; infection; pericyte.
. 2024 Jun;14(6):230349.
doi: 10.1098/rsob.230349. Epub 2024 Jun 12. Risk factors for severe COVID-19 disease increase SARS-CoV-2 infectivity of endothelial cells and pericytes
Luca Biasetti[SUP] 1 [/SUP], Nikos Zervogiannis[SUP] 1 [/SUP], Kira Shaw[SUP] 1 [/SUP], Harry Trewhitt[SUP] 1 [/SUP], Louise Serpell[SUP] 2 [/SUP], Dalan Bailey[SUP] 3 [/SUP], Edward Wright[SUP] 4 [/SUP], Catherine N Hall[SUP] 1 [/SUP]
Affiliations
- PMID: 38862017
- DOI: 10.1098/rsob.230349
Coronavirus disease 2019 (COVID-19) was initially considered a primarily respiratory disease but is now known to affect other organs including the heart and brain. A major route by which COVID-19 impacts different organs is via the vascular system. We studied the impact of apolipoprotein E (APOE) genotype and inflammation on vascular infectivity by pseudo-typed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viruses in mouse and human cultured endothelial cells and pericytes. Possessing the APOE4 allele or having existing systemic inflammation is known to enhance the severity of COVID-19. Using targeted replacement human APOE3 and APOE4 mice and inflammation induced by bacterial lipopolysaccharide (LPS), we investigated infection by SARS-CoV-2. Here, we show that infectivity was higher in murine cerebrovascular pericytes compared to endothelial cells and higher in cultures expressing APOE4. Furthermore, increasing the inflammatory state of the cells by prior incubation with LPS increased infectivity into human and mouse pericytes and human endothelial cells. Our findings provide insights into the mechanisms underlying severe COVID-19 infection, highlighting how risk factors such as APOE4 genotype and prior inflammation may exacerbate disease severity by augmenting the virus's ability to infect vascular cells.
Keywords: APOE; COVID-19; SARS-CoV-2; endothelial cell; infection; pericyte.